BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16632093)

  • 1. Germline mutations and gene polymorphism associated with human pancreatitis.
    Weiss FU; Simon P; Mayerle J; Kraft M; Lerch MM
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):289-302, viii-ix. PubMed ID: 16632093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic factors in pancreatitis.
    Grigorescu M; Grigorescu MD
    Rom J Gastroenterol; 2005 Mar; 14(1):53-61. PubMed ID: 15800694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of SPINK mutations in pancreatic development and disease.
    Liddle RA
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):345-56, x. PubMed ID: 16632097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis.
    Audrézet MP; Chen JM; Le Maréchal C; Ruszniewski P; Robaszkiewicz M; Raguénès O; Quéré I; Scotet V; Férec C
    Eur J Hum Genet; 2002 Feb; 10(2):100-6. PubMed ID: 11938439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients.
    Bernardino AL; Guarita DR; Mott CB; Pedroso MR; Machado MC; Laudanna AA; Tani CM; Almeida FL; Zatz M
    JOP; 2003 Sep; 4(5):169-77. PubMed ID: 14526128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
    Felderbauer P; Karakas E; Fendrich V; Bulut K; Horn T; Lebert R; Holland-Letz T; Schmitz F; Bartsch D; Schmidt WE
    Am J Gastroenterol; 2008 Feb; 103(2):368-74. PubMed ID: 18076731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic aspects of chronic pancreatitis.
    Teich N; Mössner J
    Med Sci Monit; 2004 Dec; 10(12):RA325-8. PubMed ID: 15567996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic trypsinogen and pancreatic secretory trypsin inhibitor gene mutations in neonatal hypertrypsinaemia.
    Patuzzo C; Castellani C; Sagramoso C; Gomez-Lira M; Bonamini D; Belpinati F; Dechecchi MC; Assael BM; Pignatti PF
    Eur J Hum Genet; 2003 Jan; 11(1):93-6. PubMed ID: 12529713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis.
    Keiles S; Kammesheidt A
    Pancreas; 2006 Oct; 33(3):221-7. PubMed ID: 17003641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis.
    Tzetis M; Kaliakatsos M; Fotoulaki M; Papatheodorou A; Doudounakis S; Tsezou A; Makrythanasis P; Kanavakis E; Nousia-Arvanitakis S
    Clin Genet; 2007 May; 71(5):451-7. PubMed ID: 17489851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary pancreatitis in Japan: a review of pancreatitis-associated gene mutations.
    Nishimori I; Onishi S
    Pancreatology; 2001; 1(5):444-7. PubMed ID: 12120222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary chronic pancreatitis.
    Teich N; Mössner J
    Best Pract Res Clin Gastroenterol; 2008; 22(1):115-30. PubMed ID: 18206817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cystic fibrosis gene mutations in determining susceptibility to chronic pancreatitis.
    Cohn JA; Mitchell RM; Jowell PS
    Gastroenterol Clin North Am; 2004 Dec; 33(4):817-37, vii. PubMed ID: 15528020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of cystic fibrosis and PSTI/SPINK1 gene mutations on susceptibility to chronic pancreatitis.
    Cohn JA; Mitchell RM; Jowell PS
    Clin Lab Med; 2005 Mar; 25(1):79-100. PubMed ID: 15749233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic issues in pediatric pancreatitis.
    Kandula L; Whitcomb DC; Lowe ME
    Curr Gastroenterol Rep; 2006 Jun; 8(3):248-53. PubMed ID: 16764792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis.
    Sobczyńska-Tomaszewska A; Bak D; Oralewska B; Oracz G; Norek A; Czerska K; Mazurczak T; Teisseyre M; Socha J; Zagulski M; Bal J
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):299-306. PubMed ID: 16954950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic aspects of chronic pancreatitis].
    Witt H; Simon P; Lerch MM
    Dtsch Med Wochenschr; 2001 Sep; 126(36):988-93. PubMed ID: 11544554
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic background of pancreatitis.
    Hirota M; Ohmuraya M; Baba H
    Postgrad Med J; 2006 Dec; 82(974):775-8. PubMed ID: 17148697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypsinogen mutations in pancreatic disorders.
    Vitone LJ; Greenhalf W; Howes NR; Raraty MG; Neoptolemos JP
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):271-87, viii. PubMed ID: 16632092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic counseling for hereditary pancreatitis--the role of molecular genetics testing for the cationic trypsinogen gene, cystic fibrosis and serine protease inhibitor Kazal type 1.
    Ellis I
    Gastroenterol Clin North Am; 2004 Dec; 33(4):839-54. PubMed ID: 15528021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.